Marc Ramis Castelltort

Marc is a co-founder and CEO at Senolytic Therapeutics Inc., a pharmaceutical company that develops a novel class of medicines by targeting senescence cells. He also supported investments and strategic partnerships at Life Biosciences Inc. in Europe. Currently, Marc is a strategic advisor at Ninevah Therapeutics, Retinset Therapeutics, Cyclomed, Cebiotex and Origen Ventures. He is a co-founder and...